LUVERIS® is used in Assisted Reproductive Technology (ART) treatments, such as in vitro fertilisation (IVF), to stimulate follicular development in women with severe luteinising hormone (LH) and follicle-stimulating hormone (FSH) deficiencies.

It is administered alongside FSH to promote the growth and maturation of ovarian follicles, increasing the chances of ovulation and successful egg retrieval.

The typical starting dose is 75 IU of LUVERIS® administered once daily via subcutaneous injection, in combination with FSH.

The dosage may be adjusted by your fertility specialist based on your response to treatment.

Treatment usually continues until adequate follicular development is achieved, as monitored through blood tests and ultrasounds.

Your doctor will provide specific instructions on the timing and duration of treatment.

If you forget to take a dose, contact your fertility clinic or doctor immediately for advice.

Do not administer a double dose to make up for the missed one.

Timing is critical in fertility treatments, so follow your doctor’s instructions closely.

In case of an overdose, seek immediate medical attention. Symptoms may include abdominal discomfort, bloating, or signs of ovarian hyperstimulation.

Contact the Poisons Information Centre (Australia: 13 11 26) or your doctor for guidance.

Store LUVERIS® below 25°C in its original packaging to protect it from light and moisture. Do not freeze the medication.

Once reconstituted, the solution should be used immediately and any remaining solution discarded.

Keep the medication out of reach of children.

Common side effects include mild redness, swelling, or itching at the injection site, which usually resolves quickly. Other possible side effects include headaches, nausea, fatigue, or abdominal discomfort.

Rare but serious side effects include symptoms of Ovarian Hyperstimulation Syndrome (OHSS), such as severe pelvic pain, nausea, vomiting, or sudden weight gain.

Contact your doctor immediately if you experience severe symptoms.

LUVERIS® may interact with other hormonal medications used during fertility treatments.

Inform your doctor about all medications, supplements, or herbal products you are taking to avoid potential interactions.

Your fertility specialist will guide you on how to safely incorporate LUVERIS® into your treatment plan.

How does LUVERIS® work in fertility treatments? LUVERIS® contains lutropin alfa, a recombinant form of luteinising hormone (LH). It works alongside follicle-stimulating hormone (FSH) to stimulate the growth and maturation of ovarian follicles, increasing the chances of ovulation and successful egg retrieval during IVF.

Can I administer LUVERIS® myself? Yes, LUVERIS® is designed for self-administration if your doctor or nurse has trained you in the proper injection technique. It is given as a subcutaneous injection, typically in the lower abdomen. Follow the instructions provided by your healthcare team carefully.

What should I do if I experience side effects? Mild side effects, such as redness or swelling at the injection site, are common and usually temporary. If you experience severe symptoms, such as signs of OHSS, contact your doctor immediately. Your healthcare team is here to support you.

Can LUVERIS® be used during pregnancy? No, LUVERIS® must not be used during pregnancy. It is specifically designed for use during ovarian stimulation cycles before conception. If you suspect you may be pregnant, inform your doctor immediately.

How should I store LUVERIS®? Store LUVERIS® below 25°C in its original packaging, away from light and moisture. Once reconstituted, the solution should be used immediately, and any remaining solution discarded.

Ace provides accurate and independent information medically reviewed on prescription medications. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.